Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 12, 2001, Pages 5686-5690

  Pacini, F ^a   Molinaro, E ^a   Lippi, F ^a   Castagna, M G ^a   Agate, L ^a   Ceccarelli, C ^a   Taddei, D ^a   Elisei, R ^a   Capezzone, M ^a   Pinchera, A ^a  

^a Department of Endocrinology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CERVICAL LYMPH NODE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

EID: 18044390652     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.12.8065     Document Type: Article

References (23)

1. An overview of the management of papillary and follicular thyroid carcinoma
2. Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
3. Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
4. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
5. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma
6. Diagnostic value of a single serum Tg determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer
7. Papillary and follicular thyroid carcinoma
8. Serum thyroglobulin concentration and 131-I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy)
9. Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma
10. 131-I therapy for elevated thyroglobulin levels
11. Serum thyroglobulin determination in thyroid cancer. A ten-year experience
12. Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: Relationship to serum thyrotropin levels
13. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy
14. Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study)
15. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma
16. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer
17. Clinical use of recombinant human TSH in thyroid cancer patients
18. Human thyroglobulin reference material 1st part: Assessment of homogeneity, stability and immunoreactivity
19. Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma
20. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
21. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
22. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-ray
23. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan